Evidence map›Paper›PMID 42749874›Full record

ReviewPituitary2026

Infiltrative and inflammatory systemic disorders involving the pituitary gland.

Betina Biagetti, Pedro Marques, Silvana Sarria-Estrada, Manel Puig-Domingo, Marta Araujo-Castro, Mónica Marazuela

Abstract readReview
In one paragraph

Review in Pituitary, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Betina Biagetti *Endocrinology & Nutrition Department, Hospital Universitario Vall d'Hebrón and Vall d'Hebron Research Institute (VHIR) ISS IR-HUVH-VHIR, Department of Medicine, Autonomous University of Barcelona, Reference Networks (Endo-ERN), Barcelona, 08035, Spain.ORCID http://orcid.org/0000-0002-8837-4343
Pedro Marques *Pituitary Tumor Unit, Endocrinology Department, Hospital CUF Descobertas, Lisbon, Portugal.
Silvana Sarria-EstradaNeuroradiology Section, Radiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
Manel Puig-DomingoGermans Trias Research Institute, Badalona, Spain.
Marta Araujo-Castro *Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal & Instituto de Investigación Ramón y Cajal (IRYCIS), Madrid, Spain.
Mónica MarazuelaEndocrinology & Nutrition Department, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Princesa &Universidad Autónoma de Madrid, Madrid, Spain. monica.marazuela@uam.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hypothalamic-pituitary region can be affected by a wide and heterogeneous group of infiltrative and inflammatory disorders, including granulomatous, histiocytic, storage, infectious, non-pituitary neoplastic, and autoimmune or inflammatory conditions collectively grouped as hypophysitis. Although individually rare, these disorders are increasingly recognized due to growing awareness, wider use of pituitary imaging, and the emergence of immune checkpoint inhibitor-induced hypophysitis. They typically present with hypopituitarism (often including arginine vasopressin deficiency, which, particularly when accompanied by pituitary stalk thickening, is highly suggestive of a non-adenomatous lesion) together with mass effect symptoms and, in many cases, systemic manifestations reflecting extrapituitary organ involvement. Neuroimaging findings, while rarely pathognomonic, can narrow the differential diagnosis, particularly when pituitary stalk involvement is present: symmetric stalk/gland enlargement with homogeneous enhancement suggests lymphocytic, IgG4-related, or granulomatous hypophysitis, whereas rim enhancement, necrosis, or bone-destructive lesions point toward infectious or neoplastic causes. A structured diagnostic work-up, combining clinical history, hormonal evaluation, targeted laboratory testing, pituitary and systemic imaging, and, when necessary, histopathological confirmation, is essential to establish an accurate diagnosis before committing patients to long-term immunosuppression or unnecessary pituitary surgery. Management requires two parallel strategies: prompt hormone replacement therapy, with urgent attention to corticotroph deficiency, and disease-specific treatment tailored to the underlying etiology, ranging from glucocorticoids and immunosuppressants to antimicrobial therapy, targeted oncologic agents, or surgery. Because pituitary deficits are frequently irreversible and several of these disorders follow a relapsing course, long-term multidisciplinary follow-up is warranted. This review summarizes the pathophysiology, clinical presentation, diagnostic approach and neuroimaging features, for infiltrative and inflammatory hypothalamic-pituitary disorders, aiming to facilitate their timely recognition and appropriate management.

Indexed as

Pituitary DiseasesPituitary GlandAutoimmune HypophysitisHumansHypophysitisHypopituitarismInflammationArginine vasopressin deficiencyGranulomatous diseaseHypophysitisHypopituitarismInfiltrative pituitary disordersPituitary stalk thickening

Identifiers

PMID42749874
PMCPMC13582242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.